Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 609 of 5804
-
New pill targets Hard-to-Treat lymphoma in early human test
Disease control CompletedThis study will treat patients with B-NHL who have relapsed, progressed, or were intolerant to systemic therapy progressed following prior therapy. This study will help to understand what type of side effects may occur with the drug treatment. It will also measure the levels of d…
Phase: PHASE1 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New Antibiotic-Coated nail aims to stop bone infections after severe leg breaks
Prevention Recruiting nowThis prospective randomized clinical trial will compare outcomes between patients treated primarily with a prophylactic antibiotic coated nail and those treated with traditional standard of care intramedullary (IM) nailing.
Phase: PHASE4 • Sponsor: Wake Forest University Health Sciences • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Gene therapy trial offers hope for rare muscle disease
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and tolerability of a single intravenous infusion of AB-1003 in adults diagnosed with limb girdle muscular dystrophy type 2I/R9 (LGMD2I/R9). Participants will be treated in sequential, dose-level cohorts. (Part 1)
Phase: PHASE1, PHASE2 • Sponsor: AskBio Inc • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New hope for brain cancer patients: experimental combo enters trials
Disease control Recruiting nowThe primary purpose of the Phase 1 (Dose Escalation) of this study is to identify the dose-limiting toxicities (DLTs) of Debio 0123 combined with temozolomide (TMZ) (Arm A) and with TMZ and radiotherapy (RT) (Arms B and C) and to characterize the safety and tolerability of these …
Phase: PHASE1, PHASE2 • Sponsor: Debiopharm International SA • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New drug aims to tame parathyroid glands in dialysis patients
Disease control CompletedThis study is to evaluate the efficacy and safety of PLS240 in patients with hemodialysis-dependent end stage kidney disease (ESKD) and secondary hyperparathyroidism (SHPT). The study consists of two phases. First, a placebo-controlled, double-blind phase where patients will be r…
Phase: PHASE3 • Sponsor: Pathalys Pharma • Aim: Disease control
Last updated Jun 26, 2026 14:53 UTC
-
New combo vaccine aims to shield seniors from two dangerous respiratory viruses
⭐️ VACCINE ⭐️ CompletedThe primary purpose of the study is to assess the safety, tolerability and immunogenicity of a bivalent respiratory syncytial virus (RSV)/human metapneumovirus (hMPV) virus-like particle (VLP) candidate vaccine (IVX-A12) compared to placebo, when administered as a single-dose reg…
Phase: PHASE2 • Sponsor: Icosavax, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:02 UTC
-
Higher-Dose eye injection may cut treatment visits for Vein-Related vision loss
Disease control CompletedResearchers are looking for a better way to treat people who have macular edema secondary to retinal vein occlusion (RVO). In people with RVO, a blood vessel that carries blood away from the retina (vein) becomes blocked. The retina is the very back part of the eye. The blocked …
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug duo aims to outsmart Platinum-Resistant ovarian cancer
Disease control Recruiting nowThis trial will treat patients with platinum resistant ovarian, fallopian tube or primary peritoneal cancer as defined by a progression free interval within six months of completion of most recent platinum-based treatment with a combination of vismodegib and atezolizumab. Despite…
Phase: PHASE2 • Sponsor: Ronald Buckanovich • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Heart clot showdown: new blood thinner vs. old standard in major trial
Disease control OngoingLeft ventricular thrombus is found in 10 to 25% of patients with impaired left ventricular function following ST-segment elevation myocardial infarction and up to 20% in dilated cardiomyopathy in observational studies. Likewise, the incidence of atrial thrombus among atrial fibri…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a drug combo turn inoperable esophageal cancer into a surgical target?
Disease control Recruiting nowThis is a single-arm, single-center, open-label, observational clinical study. A total of 30 patients with initially unresectable locally advanced esophageal squamous cell carcinoma will be enrolled.Eligible patients will receive albumin-bound paclitaxel (260 mg/m², day 1, every …
Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a shot every 6 months replace daily HIV pills?
Disease control OngoingThe goal of this study is to test the effectiveness, safety, and tolerability of the combination of broadly neutralizing antibodies (bNAbs) (teropavimab (TAB; GS-5423) and zinlirvimab (ZAB; GS-2872)) with lenacapavir (LEN) in virologically suppressed adults with HIV-1 infection. …
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New adaptive radiation aims to spare the gut in pancreatic cancer
Disease control Recruiting nowThis trial is a single-arm, prospective, multi-center clinical trial designed to demonstrate that stereotactic adaptive radiotherapy using an ablatively dosed (50Gy,5fx) for treatment of borderline-resectable, locally-advanced , or medically inoperable pancreatic adenocarcinoma w…
Phase: NA • Sponsor: Varian, a Siemens Healthineers Company • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New procedure traps chemo inside lung tumors to stop growth
Disease control Recruiting nowThis phase II trial evaluates how well transarterial chemoembolization (TACE) works for treating patients with non-small cell lung cancer or lung metastases. TACE is a minimally invasive procedure that involves injecting chemotherapy directly into an artery that supplies blood to…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Tiny nanowire implant aims to restore sight in rare eye disease
Disease control Recruiting nowThe objective of the study is to evaluate: 1. Safety of AuTNA I for subretinal implantation in patients with retinitis pigmentosa; 2. Efficacy of AuTNA I for subretinal implantation in patients with retinitis pigmentosa.
Phase: NA • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jun 26, 2026 19:14 UTC
-
New combo therapy aims to shrink Hard-to-Treat lung tumors before surgery
Disease control OngoingThe goal of this clinical trial is to test the efficacy of induction treatment of immunotherapy and chemotherapy depending on the resection status for the treatment of non small cell lung cancer patients diagnosed with pancoast tumor. The main objectives it aims to answer are: …
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a simple urine test replace the pap smear for cervical cancer screening?
Diagnosis Recruiting nowThe purpose of this study explores the usefulness of urine samples for cervical cancer screening in human immunodeficiency virus (HIV)-infected women. Cervical cancer occurs when women are infected with the human papillomavirus (HPV), which can cause changes in the cells that le…
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
New eye drops aim to speed vision recovery after cornea surgery
Disease control CompletedA study to assess the safety and efficacy of K-321 in participants with FECD after simultaneous cataract surgery and descemetorhexis.
Phase: PHASE3 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New vaccine-antibody combo takes on pancreatic cancer
Disease control OngoingThis study has stopped recruitment. Adults with advanced pancreatic cancer participate in this study. The study tests a type of immunotherapy. It is a protein treatment (ATP150/ATP152/ATP162) combined with a virus (VSV-GP154) that may kill cancer cells and help the immune system…
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Spinal cord stimulation offers hope for movement after paralysis
Disease control Recruiting nowThis study will evaluate the long-term effect of chronic spinal cord stimulation to restore volitional movement for patients with chronic spinal cord injuries.
Phase: NA • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Lupus patients get hope from Cancer-Fighting cell therapy
Disease control Recruiting nowThis is an early exploratory phase, single arm, non-randomized, open label, treatment study trial to determine the maximum tolerated dose of GC012F injection (CD19-BCMA CAR-T cells) in patients with refractory systemic lupus erythematosus.
Phase: EARLY_PHASE1 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC